Ipsen’s commitment to ethics as well as its corporate citizenship policy demonstrate the Group’s humane approach.
In France, the Ipsen group is a member of the Tulipe association, which pools medicines donated by pharmaceutical companies to meet urgent needs among populations affected by crises, natural disasters, and conflicts. For example, at the beginning of 2010, Ipsen donated boxes of Smecta® via Tulipe to help the population of Haiti.
Ipsen is also committed to the Fondation de la Deuxième Chance (“Second Chance Foundation”) whose goal is to provide human and financial support to people living in unstable conditions. Ipsen’s involvement in this mission has been by way of establishing a support site in Dreux with the aim of being as close as possible to the front line so as to better support the winners of the award to whom the association has granted help.
In Mexico, Ipsen set up the Candy Foundation with the aim of helping low-income families with children suffering from cerebral palsy. Since its creation in 2008, the Candy Foundation has opened three centers which have welcomed close to 300 children suffering from cerebral palsy.
Ipsen is a privileged contact point for learned societies, healthcare and medical institutions, and patient associations. For example, the Group works with associations supporting cancer patients in Italy and associations supporting and assisting acromegaly patients in South Korea. In the United Kingdom, the Ipsen Fund works to promote assistance for sick children. In Australia, the Group supports the Australian Pituitary Foundation, which, since 2006, has been publishing reviews aimed at informing and educating patients. The Group is also keen to work with learned societies and healthcare institutions to support research programs and training for healthcare personnel. In this context, the Group works with university and academic groups, medical centers, and associations to carry out many initiatives throughout the world. Furthermore, as part of a partnership with the Health Chair of the “Sciences Po” (school of political sciences in Paris), the Group takes a strong interest in diversifying educational programs, developing continuing education, and stimulating research in life sciences.